Published in Circ J on April 01, 2006
Effects of nitroglycerine on coronary flow velocity before and during adenosine provocation. Cardiovasc Ultrasound (2016) 0.75
Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem (2003) 3.41
Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A (2011) 2.14
Direct measurement of multiple vena contracta areas for assessing the severity of mitral regurgitation using 3D TEE. JACC Cardiovasc Imaging (2012) 2.06
Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest (2009) 1.69
Obstructive sleep apnea is associated with greater thoracic aortic size. J Am Coll Cardiol (2008) 1.68
PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation. J Clin Invest (2010) 1.63
CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.61
Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol (2006) 1.56
Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg (2003) 1.54
CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism. Circulation (2012) 1.53
Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syndrome. J Cardiovasc Electrophysiol (2005) 1.52
Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study. Pacing Clin Electrophysiol (2010) 1.48
Long-term nitrate use in acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology nitrate evaluation program). Cardiovasc Drugs Ther (2008) 1.41
Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J (2010) 1.40
Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy. J Hum Genet (2007) 1.40
Utility of multislice computed tomography as a strategic tool for complex percutaneous coronary intervention. Int J Cardiovasc Imaging (2007) 1.40
Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle. J Cell Biol (2004) 1.26
Non-invasive assessment of myocardial ischaemia using new real-time three-dimensional dobutamine stress echocardiography: comparison with conventional two-dimensional methods. Eur Heart J (2005) 1.23
Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett (2006) 1.23
Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone. Circ J (2007) 1.22
Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation (2002) 1.19
Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun (2003) 1.11
Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs (2008) 1.06
Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice. Atherosclerosis (2009) 1.04
[Prosthetic valve endocarditis caused by Streptococcus constellatus infection complicated with perivalvular abscess: serial observation by transesophageal echocardiography: a case report]. J Cardiol (2003) 1.04
Telmisartan induces proliferation of human endothelial progenitor cells via PPARgamma-dependent PI3K/Akt pathway. Atherosclerosis (2008) 1.03
Methylation of Xenopus CIRP2 regulates its arginine- and glycine-rich region-mediated nucleocytoplasmic distribution. Nucleic Acids Res (2002) 1.02
A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg (2002) 1.02
Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol (2008) 1.01
Accuracy of measurement of left ventricular volume and ejection fraction by new real-time three-dimensional echocardiography in patients with wall motion abnormalities secondary to myocardial infarction. Am J Cardiol (2004) 0.98
Helical CT features of arrhythmogenic right ventricular cardiomyopathy. Radiographics (2002) 0.96
Beneficial effects of Waon therapy on patients with chronic heart failure: results of a prospective multicenter study. J Cardiol (2008) 0.94
An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. J Vasc Surg (2002) 0.94
Primary cardiac angiosarcoma treated with carbon-ion radiotherapy. Lancet Oncol (2004) 0.92
Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia. Heart Vessels (2005) 0.92
Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. Resuscitation (2009) 0.92
Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV. J Biol Chem (2006) 0.91
Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001. Circ J (2003) 0.91
Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol (2002) 0.91
Detection of restenosis after percutaneous coronary intervention in three major coronary arteries by transthoracic Doppler echocardiography. J Am Soc Echocardiogr (2010) 0.90
Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation. Int J Cardiol (2011) 0.89
Transverse shifting of the esophagus according to the patient's position helped achieve a safe and successful pulmonary vein isolation procedure. Heart Vessels (2009) 0.88
Clinical characteristics and outcome of hospitalized patients with congestive heart failure: results of the HIJC-HF registry. Circ J (2008) 0.87
Impact of post-dilatation with a focal expanding balloon for optimization of intracoronary stenting. Heart Vessels (2007) 0.87
Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects. Heart Vessels (2010) 0.87
Levosimendan increases L-type Ca(2+) current via phosphodiesterase-3 inhibition in human cardiac myocytes. Eur J Pharmacol (2002) 0.87
A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry. Am Heart J (2005) 0.86
Prognostic significance of multiple-detector computed tomography in conjunction with TIMI risk score for patients with non-ST elevation acute coronary syndrome. Heart Vessels (2008) 0.86
Airway hyperresponsiveness in patients with coronary spastic angina: relationship between coronary spasticity and airway responsiveness. Circ J (2007) 0.84
Accessory mitral valve tissue causing severe left ventricular outflow tract obstruction in an adult. Ann Thorac Surg (2004) 0.84
The influences of psychosocial aspects and anxiety symptoms on quality of life of patients with arrhythmia: investigation in paroxysmal atrial fibrillation. Int J Behav Med (2004) 0.84
Video-assisted thoracoscopy to treat atrial tachycardia arising from left atrial appendage. J Cardiovasc Electrophysiol (2006) 0.84
Risk of sudden death in end-stage hypertrophic cardiomyopathy. J Card Fail (2011) 0.84
Utility of ECG-gated MDCT to differentiate patients with ARVC/D from patients with ventricular tachyarrhythmias. J Cardiovasc Comput Tomogr (2013) 0.83
A mitochondrial DNA variant associated with left ventricular hypertrophy in diabetes. Biochem Biophys Res Commun (2003) 0.83
Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization. Cardiovasc Diabetol (2010) 0.83
Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. Circ J (2014) 0.83
Comparison of accurate measurement of left ventricular mass in patients with hypertrophied hearts by real-time three-dimensional echocardiography versus magnetic resonance imaging. Am J Cardiol (2005) 0.82
Pulmonary hypertension during epileptic seizure with evidence of increased angiotensin II in pulmonary artery. Heart Vessels (2005) 0.82
Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program). Am J Cardiol (2007) 0.82
Routine coronary angiographic follow-up and subsequent revascularization in patients with acute myocardial infarction. Heart Vessels (2008) 0.81
Alteration in subendocardial and subepicardial myocardial strain in patients with aortic valve stenosis: an early marker of left ventricular dysfunction? J Am Soc Echocardiogr (2011) 0.81
Development of a signal-averaged vector-projected 187-channel high-resolution electrocardiogram for the evaluation of the spatial location of high-frequency potentials and abnormal ventricular repolarization. Int Heart J (2007) 0.81
Newly developed signal-averaged vector-projected 187-channel electrocardiogram can evaluate the spatial distribution of repolarization heterogeneity. Int Heart J (2008) 0.81
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: a report on two cases. J Cardiovasc Pharmacol Ther (2002) 0.81
Effects of NIP-141 on K currents in human atrial myocytes. J Cardiovasc Pharmacol (2002) 0.81
Chronic ethanol consumption increases cardiomyocyte fatty acid uptake and decreases ventricular contractile function in C57BL/6J mice. J Mol Cell Cardiol (2013) 0.81
Anatomical structure of the isthmus between the inferior vena cava and tricuspid annulus investigated with a three-dimensional electroanatomical mapping system. Heart Vessels (2005) 0.80
Acute digoxin loading reduces ABCA8A mRNA expression in the mouse liver. Clin Exp Pharmacol Physiol (2005) 0.80
Heterogeneity of hemodynamic parameters in untreated primary hypertension, and individualization of antihypertensive therapy based on noninvasive hemodynamic measurements. Clin Exp Hypertens (2012) 0.80
[Inadvertent thoracic duct puncture during right axially central venous cannulation]. Masui (2010) 0.80
Control of collagen molecular assembly with anionic polysaccharides. Biosci Biotechnol Biochem (2009) 0.80
Improvement of cardiac function and neurological remodeling in a patient with tachycardia-induced cardiomyopathy after catheter ablation. J Cardiol (2008) 0.80
Impact of myocardial reperfusion status on QT dispersion after successful recanalization of the infarct-related artery in acute myocardial infarction. J Interv Cardiol (2014) 0.80
Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: a transthoracic Doppler echocardiography study. Heart Vessels (2006) 0.79
Low-dose systemic phosphodiesterase III inhibitor pimobendan combined with prostacyclin therapy in a patient with severe primary pulmonary hypertension. Cardiovasc Drugs Ther (2003) 0.79
Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report. Cardiol Res Pract (2010) 0.79
Myocardial kinetics of (201)Thallium, (99m)Tc-tetrofosmin, and (99m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart. Ann Nucl Med (2007) 0.79
Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator. J Electrocardiol (2010) 0.79